An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the efficacy of an enteric-coated, eicosapentaenoic
acid-concentrated fish oil in the treatment of social phobia. A secondary objective is to
determine if treatment outcome is related to plasma phospholipid essential fatty acid status,
niacin skin flush and measures of lipid/protein peroxidation.